Form 4: H.B. Fuller CFO Reports Insider Stock Activity
Insider Transaction Report
H.B. Fuller's Executive VP and CFO, John J. Corkrean, reported an acquisition of phantom units and detailed existing equity holdings.
Summary
- John J. Corkrean, Executive VP and CFO of H.B. Fuller Co. (FUL), filed a Form 4 statement of changes in beneficial ownership.
- The filing reports an acquisition of 157.38 phantom units on December 19, 2025, which convert into common stock on a 1-for-1 basis.
- These phantom units were acquired at a price of $59.89 per unit and are convertible upon certain termination events or participant selection, subject to holding periods.
- Following this transaction, Corkrean beneficially owns 27,847.03 phantom units, which include units acquired pursuant to a dividend equivalent feature.
- The filing also details Corkrean's existing beneficial ownership of 54,646 shares of common stock held directly.
- Additionally, it lists various employee stock options (Right-to-Buy) totaling 267,076 underlying shares and restricted stock units totaling 8,525.57 underlying shares, with different vesting and expiration dates.
Sentiment
Score: 7
Explanation: The acquisition of phantom units by a key executive, coupled with substantial existing equity holdings, generally indicates management's confidence and alignment with shareholder interests, which is a positive signal.
Positives
- The acquisition of 157.38 phantom units by a key executive, the CFO, indicates continued alignment with shareholder interests.
- Significant existing equity holdings, including common stock, phantom units, stock options, and restricted stock units, demonstrate a strong vested interest in the company's long-term performance by a senior executive.
Negatives
- No significant negative transactions or disclosures were reported in this Form 4 filing.
Risks
- This Form 4 filing primarily reports insider transactions and does not contain specific risk factors related to the company's operations or financial health.
Future Outlook
This Form 4 filing primarily reports insider transactions and beneficial ownership, and does not contain forward-looking statements or guidance regarding the company's future performance or strategic outlook.
Industry Context
Form 4 filings are routine disclosures of insider trading activity. The acquisition of phantom units by a key executive like the CFO can be viewed as a positive signal of management's confidence in the company's future, aligning their interests with shareholders. This is a common practice in executive compensation structures across various industries.
Comparison to Industry Standards
- Insider buying, particularly by a CFO, is generally viewed as a positive indicator, suggesting management's confidence in the company's future prospects.
- While this filing does not provide specific comparable company data or project results, the structure of equity compensation (phantom units, stock options, RSUs) is standard practice across publicly traded companies, including those in the specialty chemicals and industrial materials sector where H.B. Fuller operates.
- The acquisition of phantom units, likely part of a deferred compensation plan, aligns with typical executive incentive structures designed to tie executive wealth to shareholder value. The volume of the acquisition is consistent with routine compensation awards rather than a significant discretionary open market purchase.
Stakeholder Impact
- Shareholders: The acquisition of phantom units by the CFO may be viewed positively as it aligns management's interests with shareholder value creation.
- Employees: The existence of various equity compensation plans (stock options, RSUs, phantom units) indicates a structured approach to executive and potentially broader employee incentives.
Next Steps
- This filing does not specify any future actions, events, or milestones for the company or the reporting person beyond the vesting schedules of the reported equity awards.
Key Dates
| Date | Description |
|---|---|
| 01/26/2018 | Date exercisable for Employee Stock Option with exercise price $50.10, 100% vested. |
| 01/25/2019 | Date exercisable for Employee Stock Option with exercise price $53.57, 100% vested. |
| 01/24/2020 | Date exercisable for Employee Stock Option with exercise price $45.05, 100% vested. |
| 01/24/2021 | Date exercisable for Employee Stock Option with exercise price $48.35, 100% vested. |
| 01/27/2022 | Date exercisable for Employee Stock Option with exercise price $51.89, 100% vested. |
| 01/24/2023 | Date exercisable for Employee Stock Option with exercise price $72.94, 100% vested. |
| 01/24/2024 | Date exercisable for Employee Stock Option with exercise price $68.17 (vests in three annual installments). Also, vesting date for Restricted Stock Units (vests in three annual installments) expiring 01/24/2026. |
| 01/26/2025 | Date exercisable for Employee Stock Option with exercise price $77.72 (vests in three annual installments). Also, vesting date for Restricted Stock Units (vests in three annual installments) expiring 01/26/2027. |
| 12/19/2025 | Transaction date for acquisition of 157.38 Phantom Units. Also, vesting date for Phantom Units (convertible upon certain termination events or participant selection). |
| 12/22/2025 | Signature date of the reporting person's attorney-in-fact. |
| 01/24/2026 | Expiration date for Restricted Stock Units. |
| 01/27/2026 | Date exercisable for Employee Stock Option with exercise price $64.28 (vests in three annual installments). Also, vesting date for Restricted Stock Units (vests in three annual installments) expiring 01/27/2028. |
| 01/26/2027 | Expiration date for Employee Stock Option with exercise price $50.10. Also, expiration date for Restricted Stock Units. |
| 01/25/2028 | Expiration date for Employee Stock Option with exercise price $53.57. |
| 01/27/2028 | Expiration date for Restricted Stock Units. |
| 01/24/2029 | Expiration date for Employee Stock Option with exercise price $45.05. |
| 01/24/2030 | Expiration date for Employee Stock Option with exercise price $48.35. |
| 01/27/2031 | Expiration date for Employee Stock Option with exercise price $51.89. |
| 01/24/2032 | Expiration date for Employee Stock Option with exercise price $72.94. |
| 01/24/2033 | Expiration date for Employee Stock Option with exercise price $68.17. |
| 01/26/2034 | Expiration date for Employee Stock Option with exercise price $77.72. |
| 01/27/2035 | Expiration date for Employee Stock Option with exercise price $64.28. |
Recommendation
holdThis Form 4 filing details a routine insider transaction involving the acquisition of phantom units by the CFO, alongside a comprehensive disclosure of existing equity holdings. While the acquisition itself is a positive signal of management's alignment and confidence, it is a relatively small transaction likely tied to compensation rather than a significant open market purchase. The filing does not provide new financial performance data or strategic updates that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific insider report.
Keywords
H.B. Fuller, FUL, Insider Trading, Form 4, Executive Compensation, Phantom Units, Stock Options, Restricted Stock Units, John J. Corkrean
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.